June 17, 2013

CAS databases provide millions of journal article references from more than 10,000 major scientific journals worldwide, patent and patent family references from 63 patent authorities around the world, and other reputable web sources.

The following patent record is from the CAplusSM database.


Patent Number: WO 2013054108
Title: Preparation of Mono-fluoro spiro compounds as beta-secretase inhibitors for treating amyloid beta related pathologies
Inventor(s): Minidis, Anna; Rahm, Fredrik; Viklund, Jenny
Patent Assignee(s): AstraZeneca AB, Swed.; AstraZeneca UK Limited
Source: PCT Int. Appl., 90 pp. CODEN: PIXXD2
Language: English

Beta-secretase inhibitors of formula I (wherein A is -O-, -CH2-, -CH2CH2-, -OCH2-, -CH2O-, or -CF2-; n = 0-1; R1 is H, C1-6 alkyl or C0-6-alkylC3-6cycloalkyl; R2 is (un)substituted C0-6-alkylaryl, (un)substituted C0-6-alkylheteroaryl, etc.; R3 is H; R4 is H; R5 and R6 are independently H, (un)substituted heterocyclyl, (un)substituted aryl, etc., or together form part of a ring; and R9 is one or more substituents selected from H, F, OH, CH3, Cl or OCH3), pharmaceutical compns. comprising them and therapeutic methods using them for the treatment and/or prevention of Abeta-related pathologies are claimed.  Such pathologies include Down's syndrome, beta-amyloid angiopathy such as but not limited to cerebral amyloid angiopathy or hereditary cerebral hemorrhage, disorders assocd. with cognitive impairment such as but not limited to MCI ("mild cognitive impairment"), Alzheimer's Disease, memory loss, attention deficit symptoms assocd. with Alzheimer's disease, neurodegeneration assocd. with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia assocd. with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration.  Synthetic procedures for prepg. I are exemplified.  Example compd. II was prepd. by Suzuki coupling of the corresponding 6'-bromo spiro intermediate (mixt. of isomers) and 5-(prop-1-ynyl)pyridin-3-ylboronic acid.  In a TR-FRET assay using the sol. part of the human beta-secretase, II had an IC50 of 18 nM.

Please note:  Abstracts and Titles for patent records in CAplus are routinely enhanced to better describe the claimed invention. The actual title of the patent is Mono-fluoro beta-secretase inhibitors.

 View the full-text here.

Recent News

    October 28, 2015 | CAS and Influential Research
    Leaders in Japan Share Common Business
    Challenges in Driving Economic Development
    through Scientific Research

    September 1, 2015 | BizInt Smart Charts and New
    STN Collaboration Extends and Optimizes Intellectual
    Property Search Workflow

    August 7, 2015 | CAS Announces the 2015 SciFinder
    Future Leaders in Chemistry and First-Ever Alumni

                                                                    More News >> 

Media Contact

 Name: Rhonda Ross
 Phone: 614-447-3624
 Email: cas-pr@cas.org